Picard Medical is trading 7.67% up at $6.74, driven mainly by speculative momentum and heavy volatility rather than a confirmed catalyst.
- The move extends sharp rallies from September 11 and September 14.
- No new company-specific announcement for September 15, 2026 has been identified; recent coverage highlights ongoing shareholder investigations and earlier financial news.
- Healthcare’s strength offers limited sector support, while broader markets are modestly lower.